Dinis Calado
GROUP LEADER (2ND 6)
Dinis joined Cancer Research UK's London Research Institute (now part of the Francis Crick Institute) as a group leader in 2013 after his postdoctoral research at Harvard Medical School in Boston.
His research aims to elucidate mechanisms by which healthy cells of the haematopoietic system become cancerous, with major focus on B lymphocytes. Using state of the art mouse genetics, he has generated bona fide mouse models of cancer, including diffuse large B cell lymphoma, and Burkitt lymphoma, and has identified in vivo subpopulations of B cells with high c-Myc expression, that may represent precursors of these diseases.
Qualifications and history
2006
University of Lisbon, Portugal
PhD in Molecular Immunology
2006
Harvard Medical School, USA
Postdoctoral Fellow
2010
Harvard Medical School, USA
Special Fellow of the Leukemia Lymphoma Society
2013
London Research Institute, Cancer Research UK
Established Lab
2015
The Francis Crick Institute, London, UK
Group Leader
Research topics
- Chemical Biology & High Throughput (18)
- Computational & Systems Biology (6)
- Developmental Biology (18)
- Gene Expression (1)
- Genetics & Genomics (18)
- Genome Integrity & Repair (5)
- Human Biology & Physiology (2)
- Imaging (2)
- Immunology (18)
- Infectious Disease (1)
- Model Organisms (18)
- Signalling & Oncogenes (18)
- Stem Cells (18)
- Structural Biology & Biophysics (3)
- Tumour Biology (18)
Publication type
Journal
- Cancer Cell (3)
- Cancer Immunology Research (1)
- Cell Chemical Biology (1)
- Cell Reports (2)
- Circulation Research (1)
- eLife (1)
- Frontiers in Immunology (1)
- Frontiers in Molecular Biosciences (1)
- Haematologica (1)
- Immunity (2)
- Journal of Experimental Medicine (2)
- Leukemia (1)
- Methods in Molecular Biology (1)
- Molecular Neurodegeneration (1)
- Nature Communications (2)
- Nature Immunology (1)
- Oncoimmunology (1)
- Proceedings of the National Academy of Sciences of USA (1)
Crick Pre-Crick
Displaying 1 - 20 of 24
Last updated : 07 June 2023 02:37
